Biovie Inc (BIVI) Hedge Fund & Institutional Holdings (Q2 2026)

BIVI ranks #6948 out of 37505 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

BIVI is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

37 institutions disclose a position in BIVI, but none treat it as a major bet — even Diametric Capital, LP, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

Morgan Stanley has added to its BIVI position for two straight quarters, increasing it by $1.1M to reach $1.2M today.

BIVI reported a net loss of $22.1M in its latest fiscal year.

• Not yet profitable — net loss of $22.1M in the latest fiscal year
• Net income declined year over year, from -$17.5M to -$22.1M
• Operating cash flow was negative, using $19.0M in cash
• Current ratio of 3.59x — enough short-term assets to cover short-term liabilities
• Liabilities run 5278.77x equity — a highly leveraged balance sheet worth noting